Who founded Emulatebio?

Emulatebio was founded by Donald Ingber, Daniel Levner in 2014.

Who are Emulatebio's investors?

Emulatebio's investors include +ND Capital, Northpond Ventures, Alwyn Capital, Fourth Realm, Stray Dog Capital, OS Fund, Starlight Ventures.

Emulatebio

Founded 2014 · 73 employees on LinkedIn · 7 known investors

Find your way into Emulatebio

395 people in our graph share verified history with the Emulatebio team — schools, employers, funds. One of them is your warm intro.

Sam Blackmanunlockedknows Donald Ingber · together at Boston Children's Hospital (overlapped)

×6knows the team · via Harvard Medical School

×3knows the team · via Boston Children's Hospital

knows the team · via Harvard John A. Paulson School of Engineering and Applied Sciences

knows the team · via Yale School of Medicine

Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research. It serves life sciences and pharmaceutical researchers and provides installation, training, and validated protocols for Organ-Chip experiments.

Biotech Deep Tech Healthtech

Founders & leadership

Emulatebio was founded in 2014 by Donald Ingber and Daniel Levner.

Donald Ingber inScientific Founder, Board Member, Scientific Advisory Board ChairmanDonald Ingber is a researcher in mechanobiology and tissue engineering who holds the Founding Director role at the Wyss Institute at Harvard University and has published over 500 scientific works and holds more than 200 patents. He co-founded Emulatebio and has founded eight companies developing technologies spanning therapeutics, medical devices, diagnostics, and organ-chip platforms for drug discovery and clinical applications.

Daniel LevnerinCo-Founder & CTO

Jim CorbettinCEO, Board Member

Lorna EwartinChief Scientific Officer

Investors · 7

+ND Capital✓ verifiedWoodside · $540K – $5.4M

Northpond Ventures✓ verifiedBethesda · $100K – $5M

Alwyn CapitalSt. Petersburg

Fourth RealmMenlo Park

Stray Dog CapitalLeawood · $100K – $1M

OS FundreportedPark Ridge · $1M – $2M

Starlight VenturesreportedMiami · $100K – $3M

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2018	$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Emulatebio do?: Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research. It serves life sciences and pharmaceutical researchers and provides installation, training, and validated protocols for Organ-Chip experiments.
Who founded Emulatebio?: Emulatebio was founded by Donald Ingber, Daniel Levner in 2014.
Who are Emulatebio's investors?: Emulatebio's investors include +ND Capital, Northpond Ventures, Alwyn Capital, Fourth Realm, Stray Dog Capital, OS Fund, Starlight Ventures.